Results 41 to 50 of about 23,835 (226)

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study

The Lancet Public Health, 2018
Background: In 2013, a herpes zoster vaccination programme was introduced in England for adults aged 70 years with a phased catch-up programme for those aged 71–79 years.
Gayatri Amirthalingam, MFPH, Nick Andrews, PhD, Philip Keel, MSc, David Mullett, MA, Ana Correa, MSc, Simon de Lusignan, MD, Mary Ramsay, FFPH   +6 more
doaj   +1 more source

Herpes Zoster in an Immunocompetent Child without a History of Varicella

Pediatric Reports, 2021
Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella−Zoster virus.
Bing-Shiau Shang, Cheng-Jui Jamie Hung, Ko-Huang Lue   +2 more
doaj   +1 more source

Risk of Herpes Zoster in Individuals on Biologics, DMARDS and/or Corticosteroids for Autoimmune Diseases:A Systematic Review and Meta-Analysis [PDF]

, 2016
Background: Studies examining the risk of herpes zoster (HZ) associated with immunosuppressants, such as biologics, non-biological disease modifying agents (nbDMARDs) or corticosteroids, have generated conflicting results.
Alarcón-Segovia, Bachelez, Bejarano, Bongartz, Braun, Brenner, Bresnihan, Cardiel, Che, Chen, Choy, Cohen, Cutolo, Dechartres, Dixon, Dixon, Dreiher, Egger, Emery, Emery, Fleischmann, Fleischmann, Furie, Furst, Galloway, Genovese, Genovese, Gupta, Gupta, Harpaz, Hayward, Higgins, Higgins, Hoes, Kameda, Kawai, Keystone, Kost, Kourbeti, Kremer, Kremer, Kremer, Kremer, Lal, Leonardi, Long, McDonald, Merrill, Moher, Moreland, Moutsopoulos, Nakajima, Nishimoto, Osterman, Oxman, Oxman, Papp, Pappas, Peto, Rutgeerts, Sampathkumar, Sandborn, Sandborn, Schiff, Schreiber, Segan, Shah, Singh, Smitten, Smolen, Smolen, Spittal, Strangfeld, Stroup, Sweeting, Takeuchi, Tanaka, Tanaka, van der Heijde, van Vollenhoven, Veetil, Weiner, Wells, Winthrop, Winthrop, Winthrop, Wolfe, Yamamoto, Yawn, Yawn, Youssef, Yun, Zhang, Zisman, Zorzela   +94 more
core   +1 more source

Herpes Zoster Vaccine

Uirusu, 2018
Herpes zoster, or shingles, results from the reactivation of latent varicella- zoster virus (VZV) in the dorsal-root or cranial-nerve ganglia, usually decades after primary infection. Herpes zoster is characterized by a vesicular rash with a unilateral and dermatomal distribution and is almost always accompanied by pain.
openaire   +3 more sources

Herpes zoster subunit vaccine for the prevention of herpes zoster

American Journal of Health-System Pharmacy, 2018
Published literature on the efficacy and safety of the herpes zoster (HZ) subunit vaccine (HZ/su vaccine) in reducing the risks of HZ and postherpetic neuralgia (PHN) in adults 50 years of age and older, as well as the vaccine's properties and efficacy relative to live attenuated vaccine, is reviewed.HZ/su vaccine (Shingrix, GlaxoSmithKline) is a ...
Symoniak, Melanie, Farrokh, Pejman, Gandhi, Mona A., Slish, Judianne   +3 more
openaire   +4 more sources

Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.

PLoS ONE, 2021
ObjectivesComprehensive cost-effectiveness analyses of introducing varicella and/or herpes zoster vaccination in the Swedish national vaccination programme.DesignCost-effectiveness analyses based on epidemiological results from a specifically developed ...
Ellen Wolff, Katarina Widgren, Gianpaolo Scalia Tomba, Adam Roth, Tiia Lep, Sören Andersson   +5 more
doaj   +1 more source

Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study. [PDF]

, 2016
OBJECTIVE: To investigate risk factors for postherpetic neuralgia, the neuropathic pain that commonly follows herpes zoster. METHODS: Using primary care data from the Clinical Practice Research Datalink, we fitted multivariable logistic regression models
Bhaskaran, Krishnan, Clayton, Tim, Forbes, Harriet J, Langan, Sinéad M, Mansfield, Kathryn, Minassian, Caroline, Smeeth, Liam, Thomas, Sara L   +7 more
core   +1 more source

Herpes Zoster After Yellow Fever Vaccination [PDF]

Journal of Travel Medicine, 2007
An immunocompetent 64-year-old women presented with brachial herpes zoster (HZ) infection 3 days after vaccination against yellow fever (YF). The lesions disappeared after antiviral treatment. There are very few reports of a possible association between YF vaccination and HZ infection.
Jose-Maria, Bayas, Raquel, González-Alvarez, Caterina, Guinovart   +2 more
openaire   +2 more sources

Herpes zoster vaccination in systemic lupus erythematosus: the current status

Human Vaccines & Immunotherapeutics, 2019
Among the inflammatory rheumatic diseases, SLE is associated with the highest risk of herpes zoster reactivation relative to age. The reported incidence of herpes zoster infection in SLE ranges from 6.4 to 91.4/1000 patient-years, with main risk factors ...
Chi Chiu Mok
doaj   +1 more source

Vaccines for prophylaxis of viral infections in patients with hematological malignancies. [PDF]

, 2011
Viral infections cause significant morbidity and mortality in patients with hematological malignancies. It remains uncertain whether viral vaccinations in these patients are supported by good evidence.
Chan, GC, Cheuk, DK, Chiang, AK, Ha, SY, Lee, TL   +4 more
core   +1 more source